Status:
COMPLETED
Botulinum Toxin and Mesotherapy on Enhancement of Facial Scarring
Lead Sponsor:
Hams Hamed Abdelrahman
Conditions:
Facial Scars
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
Most of the body's tissues can undergo wound repair following a disruption of tissue integrity. Upon healing, these wounds result in scar formation. The scars widen when the overlying musculature pull...
Eligibility Criteria
Inclusion
- Patient suffering from vertical or oblique forehead lacerations caused by trauma.
- Recent and fresh wounds.
- Atrophic scar (linear scar).
Exclusion
- Infected wound.
- Patient on chemotherapy treatment and history of malignancy.
- Patients suffering from burns on the forehead or complicated lacerations.
- Allergy to drugs used in this study
Key Trial Info
Start Date :
November 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2024
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06562023
Start Date
November 19 2022
End Date
July 20 2024
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University
Alexandria, Egypt